But the list of possible side effects carries a much more somber tone: pancreatitis, pancreatic cancer, urinary infections, thyroid cancer, gastrointestinal issues, and renal and gallbladder problems.
In a groundbreaking report, AdverseEvents (AE), a California-based company that analyzes post-market side effect data, reveals the real-world problems with these newer drugs.
“The only way to fully review a drug’s safety is to track and monitor side effects as the general population begins utilizing the drugs on an ongoing basis, in real-world circumstances,” Brian Overstreet, CEO of AdverseEvents, said in a statement.
While it’s hard to argue with the data – real people reporting real side effects to the U.S. Food and Drug Administration (FDA) – the report is sure to face scrutiny. The primary point of controversy? Whether these drugs are or are not linked to pancreatic cancer.
The report says yes.